Clinical trial
Chemoradiation-Induced Nausea and Emesis: Quality of Life
NCT00394602 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00394602 |
|---|---|
| Title | Chemoradiation-Induced Nausea and Emesis: Quality of Life |
| Official title | Chemoradiation-Induced Nausea and Emesis: A Prospective Study to Assess Patient Preferences and Quality of Life |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Gastric Cancer, Pancreatic Cancer, Cervical Cancer, Vulvar Cancer, Endometrial Cancer, Anal Cancer |
| Intervention type | Behavioral, Other |
| Interventions | Interview, Questionnaire |
| Enrollment | 207 |
| Start date | Apr 7, 2004 |
| Primary completion | May 8, 2019 |
| Completion | May 8, 2019 |
| First posted | Nov 1, 2006 |
| Last update posted | Jan 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: